| Dr Solimar Pedraza-negron, MD | |
|
111 E 210th St, Bronx, NY 10467-2401 | |
| (718) 920-6626 | |
| (718) 798-0730 |
| Full Name | Dr Solimar Pedraza-negron |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 18 Years |
| Location | 111 E 210th St, Bronx, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013238203 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 257440 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Cross Hospital | Fort lauderdale, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Holy Cross Urgent Care | 7618389248 | 13 |
News Archive
At a press conference held in Brussels today, the International Osteoporosis Foundation (IOF), the Belgian Bone Club and the European Parliament Osteoporosis Interest Group called on health care professionals and health policy officials in Europe to take action to prevent spinal fractures. The call to action was made at the launch of a unique photographic essay, 'snap! the breaking spine', leading up to World Osteoporosis Day on October 20, 2010.
Families with food-allergic children face a life of constant vigilance and the looming fear of life-threatening allergic reactions. This fear can have a huge impact on an entire family's life, from heightened anxiety to severe limits on their daily activities. Some families cope well with this situation, while others find it extremely stressful and difficult to manage.
Aviv REIT, Inc. announced today it has acquired eight post-acute and long-term care skilled nursing facilities ("SNFs") in California and Texas, in three separate transactions for $70.7 million.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced the successful completion of a short-term safety, tolerability, and pharmacokinetic study of VK5211 in healthy elderly subjects. VK5211, the company's lead program for muscle and bone disorders, is an orally available, non-steroidal selective androgen receptor modulator (SARM) being developed for the treatment of patients recovering from non-elective hip fracture surgery.
› Verified 9 days ago
| Entity Name | Holy Cross Urgent Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144824699 PECOS PAC ID: 7618389248 Enrollment ID: O20201223001274 |
News Archive
At a press conference held in Brussels today, the International Osteoporosis Foundation (IOF), the Belgian Bone Club and the European Parliament Osteoporosis Interest Group called on health care professionals and health policy officials in Europe to take action to prevent spinal fractures. The call to action was made at the launch of a unique photographic essay, 'snap! the breaking spine', leading up to World Osteoporosis Day on October 20, 2010.
Families with food-allergic children face a life of constant vigilance and the looming fear of life-threatening allergic reactions. This fear can have a huge impact on an entire family's life, from heightened anxiety to severe limits on their daily activities. Some families cope well with this situation, while others find it extremely stressful and difficult to manage.
Aviv REIT, Inc. announced today it has acquired eight post-acute and long-term care skilled nursing facilities ("SNFs") in California and Texas, in three separate transactions for $70.7 million.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced the successful completion of a short-term safety, tolerability, and pharmacokinetic study of VK5211 in healthy elderly subjects. VK5211, the company's lead program for muscle and bone disorders, is an orally available, non-steroidal selective androgen receptor modulator (SARM) being developed for the treatment of patients recovering from non-elective hip fracture surgery.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Solimar Pedraza-negron, MD 111 E 210th St, Bronx, NY 10467-2401 Ph: (718) 920-6626 | Dr Solimar Pedraza-negron, MD 111 E 210th St, Bronx, NY 10467-2401 Ph: (718) 920-6626 |
News Archive
At a press conference held in Brussels today, the International Osteoporosis Foundation (IOF), the Belgian Bone Club and the European Parliament Osteoporosis Interest Group called on health care professionals and health policy officials in Europe to take action to prevent spinal fractures. The call to action was made at the launch of a unique photographic essay, 'snap! the breaking spine', leading up to World Osteoporosis Day on October 20, 2010.
Families with food-allergic children face a life of constant vigilance and the looming fear of life-threatening allergic reactions. This fear can have a huge impact on an entire family's life, from heightened anxiety to severe limits on their daily activities. Some families cope well with this situation, while others find it extremely stressful and difficult to manage.
Aviv REIT, Inc. announced today it has acquired eight post-acute and long-term care skilled nursing facilities ("SNFs") in California and Texas, in three separate transactions for $70.7 million.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced the successful completion of a short-term safety, tolerability, and pharmacokinetic study of VK5211 in healthy elderly subjects. VK5211, the company's lead program for muscle and bone disorders, is an orally available, non-steroidal selective androgen receptor modulator (SARM) being developed for the treatment of patients recovering from non-elective hip fracture surgery.
› Verified 9 days ago
Dr. Thomas Henry Parry, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 234 E 149th St, Bronx, NY 10451 Phone: 718-579-6010 | |
May Yee Helman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-992-7669 | |
Dr. Angelica Rosa Angiulli, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1825 Eastchester Rd, Bronx, NY 10461 Phone: 718-904-2904 | |
Dr. Patrick Spencer Eiben, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 Pelham Pkwy S, Building 6//suite B125, Bronx, NY 10461 Phone: 718-918-5820 | |
Nai Li, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4422 3rd Ave, Bronx, NY 10457 Phone: 718-960-9000 | |
Vinay Saggar, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1400 Pelham Pkwy S Ste B125, Bronx, NY 10461 Phone: 718-918-5820 | |
Joshua Ronald Gravel, MD, MSC Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 234 E 149th St, Bronx, NY 10451 Phone: 239-233-1156 |